Molecular pharmacology of ciclesonide against SARS-CoV-2

J Allergy Clin Immunol. 2020 Aug;146(2):330-331. doi: 10.1016/j.jaci.2020.05.029. Epub 2020 Jun 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / chemistry
  • Antiviral Agents / metabolism
  • Antiviral Agents / pharmacology*
  • Betacoronavirus / drug effects*
  • Betacoronavirus / enzymology
  • Betacoronavirus / genetics
  • Binding Sites
  • COVID-19
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / virology
  • Endoribonucleases / antagonists & inhibitors*
  • Endoribonucleases / chemistry
  • Endoribonucleases / genetics
  • Endoribonucleases / metabolism
  • Gene Expression
  • Glucocorticoids / chemistry
  • Glucocorticoids / metabolism
  • Glucocorticoids / pharmacology*
  • Humans
  • Molecular Dynamics Simulation
  • Pandemics
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / virology
  • Pregnenediones / chemistry
  • Pregnenediones / metabolism
  • Pregnenediones / pharmacology*
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • Protein Structure, Secondary
  • RNA-Dependent RNA Polymerase / chemistry
  • RNA-Dependent RNA Polymerase / genetics
  • RNA-Dependent RNA Polymerase / metabolism
  • SARS-CoV-2
  • Structural Homology, Protein
  • Thermodynamics
  • Viral Nonstructural Proteins / antagonists & inhibitors*
  • Viral Nonstructural Proteins / chemistry
  • Viral Nonstructural Proteins / genetics
  • Viral Nonstructural Proteins / metabolism
  • Virus Replication / drug effects*

Substances

  • Antiviral Agents
  • Glucocorticoids
  • Pregnenediones
  • Viral Nonstructural Proteins
  • RNA-Dependent RNA Polymerase
  • Endoribonucleases
  • nidoviral uridylate-specific endoribonuclease
  • ciclesonide